Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Techniclone (TCLN) -- Ignore unavailable to you. Want to Upgrade?

To: Terry D. who wrote (2976)	4/1/1999 8:47:00 PM
From: TJG	Read Replies (1) \| Respond to of 3702

Everything that I could find on subject @ nbc.com.. Any of this related to TCLN ? msnbc.com Good luck all... TJG

To: Terry D. who wrote (2976)	4/1/1999 8:49:00 PM
From: Dave Belz	Read Replies (3) \| Respond to of 3702

I am reporting to you from a meeting I had yesterday at the Techniclone offices in Tustin with the CEO Larry Bymaster, Chairman of the Board Tom Testman, CFO Steve Burke, two principal nvestors in our investment group and an investment banker friend that we invited to the meeting. The purpose of the meeting was to obtain an overview of the current condition of the company. The meeting started with one of our investors explaining to Bymaster that many of the individuals in our group of investors were concerned about the current flurry of rumors about the company. We impressed upon him that we would like to see more communication by him with the shareholders and the investment community. He listened. We impressed upon him that most shareholders are not aware of the management accomplishments at Tustin in the last year. He listened. We told him that we as shareholders would like to help in any way we could to support the company. He listened. We suggested to him the “story of techniclone” was not being told. He listened. He was concerned that we were concerned and was very happy to share with us the goings on at techniclone. Bymaster then went on to explain that when he came to the company there was a need to manage the company. Tom Testman had done a good job in cleaning up some of the organizational deficiencies. When he took over for Testman, Bymaster focused his efforts on establishing a management mentality and organization so the company could efficiently execute its strategic goals which are to commercialize the broad pipeline of products. He had to retool the work mentality of the employees. We all know how execution was lacking in the past. The staff has been cut to conserve capital. Key people have been replaced with new people that understand that this is a full time job. The use of capital is now directed toward clinical trials. All of these changes have enabled the company to move forward in the most efficient way to commercialize the products. Commercialization of the Techniclone pipeline is the objective. The Lym deal with Scherring was an important milestone. Hopefully we will have another licensing deal soon on VTA that will further improve our financial condition as well as our visibility in the financial community ( the company has 60 patents and more on the way. Other companies developing angiogenesis products now have to deal with TCLN ). Unlike before the events of the past year, the medical world is now starting the take note of Techniclone and that will bring more opportunities to the company. The Ph I data for TNT will be presented at AASCO on May 15. Dr Epstein and Dr Thorpe will be presenting at AACR in April. By the way, Epstein and Thorpe are working closely with Bymaster in the development of the other non clinical products. I personally know Epstein is very enthusiastic about the current management situation at TCLN. And more importantly Bymaster indicated the TNT Phase II trials for non operative brain cancer are going well. Our investment banker friend was invited to the meeting to see if he would be interested in helping the company. He sat through the meeting and listened. After hearing the questions and answers he asked a few questions of his own. We then asked him about his impressions. He said it appeared to him the company is being managed well. He was also impressed with the science and technology. He believes that the company is now ready to move forward in accomplishing it goals but will need the support of the current shareholders and the investment community. He said he had a number of ideas on how to improve the companies capital position and to move the stock price higher. He would like to have some time to formulate those ideas and then come back to have further discussions with management. To me, the important point here was his impression of Bymaster, and Burke. He said more than once that he was very impressed with the presentation and both of them. He is a young very successful investment banker that deals with a lot of small firms like techniclone. What he heard about the history of the company and problems in the past were nothing new to him. He did not hear anything that overly concerned him. He said they have done a good job with what they were given and have positioned the company to move to the next level. There will be follow up iscussions with the investment banker. The company now is putting together an information campaign to update current shareholders and potential new investors. Rubenstein is starting to help on that, ie the NBC story. Also, Bymaster will be sending a letter to shareholders to tell them what is happening and what the company hopes to accomplish in the next year. This was the first time I had met Larry Bymaster. I was elated when I left Techniclone that day. The other members of our investment group felt the same way. I believe he is doing a good job of managing the company. I believe he is willing to listen to the shareholders and certainly welcomes your support. He also understands that this is more than a money making venture. The most important accomplishment here will be in what we can do for others who are cursed with fatal diseases and have no other hope than what Techniclone's science can give them. What Bymaster needs is investors in this company, not traders. People who understand that this is one of the most signficant investments in their portfolio both from and captial gain standpoint, but more importantly from a humanitarian standpoint.